Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment
Completed · Phase 2
Conditions studied: Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
In brief
The main purpose of this study was to assess the progression-free survival (PFS) based on local investigator assessment of pazopanib in participants with advanced and/or metastatic renal cell carcinoma (mRCC) following prior treatment with immune checkpoint inhibitors (ICI).
Key facts
- Study ID
- NCT03200717
- Run by
- Novartis Pharmaceuticals
- People needed
- 62
- Starts
- 2017-11-14
- Expected to finish
- 2021-08-10
- Last updated by the study team
- 2023-08-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Novartis Investigative Site — Caba, Buenos Aires, Argentina
- Novartis Investigative Site — Graz, Austria
- Novartis Investigative Site — Salzburg, Austria
- Novartis Investigative Site — Vienna, Austria
- Novartis Investigative Site — Calgary, Alberta, Canada
- Novartis Investigative Site — Temuco, Araucania, Chile
- Novartis Investigative Site — Santiago, Chile
- Novartis Investigative Site — Brno, Czech Republic, Czechia
- Novartis Investigative Site — Olomouc, CZE, Czechia
- Novartis Investigative Site — Paris, France
- Novartis Investigative Site — Strasbourg, France
- Novartis Investigative Site — Valenciennes, France
- Novartis Investigative Site — Hanover, Germany
- Novartis Investigative Site — Jena, Germany
- Novartis Investigative Site — Tübingen, Germany
- Novartis Investigative Site — Budapest, Hungary
- Novartis Investigative Site — Seville, Andalusia, Spain
- Novartis Investigative Site — Madrid, Spain
- Novartis Investigative Site — London, United Kingdom
- Novartis Investigative Site — Manchester, United Kingdom
- Novartis Investigative Site — Preston, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.